Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-018723
Filing Date
2017-07-21
Accepted
2017-07-21 19:05:42
Documents
1
Period of Report
2017-07-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3883
  Complete submission text file 0000899243-17-018723.txt   5380
Mailing Address C/O AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300 BRISBANE CA 94005-1884
Business Address
Sheehy Douglas T. (Reporting) CIK: 0001488637 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37519 | Film No.: 17977362

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Issuer) CIK: 0001631650 (see all company filings)

EIN.: 452748244 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations